REVIVA PHARMACEUTICALS HOLDINGS, INC. Inactive Instrument
Calendar Reviva Pharmaceuticals Holdings, Inc. Nasdaq
Equities
TZAC
US76152G1004
Chart calendar Reviva Pharmaceuticals Holdings, Inc.
800d055f79c.qkfYRKoY19YX6bAYmzwMVsDKz9gkQQS_AfIsYSMXnQ0.7RO7c5Nqhrtjjv553GxFPJaGhKxdE3HuUqhnNxRk_EnmFL4B3mHnj3DR9Q~bbcec1f3337870b6841d93c6b86c9de6
Upcoming events on Reviva Pharmaceuticals Holdings, Inc.
Past events on Reviva Pharmaceuticals Holdings, Inc.
| 29/05/2024 | Lytham Partners Spring Investor Conference |
| 21/05/2024 17:15 | American Thoracic Society Conference - Poster No : 15059 |
| 20/05/2024 | Benchmark Healthcare House Virtual Conference |
| 14/05/2024 13:00 | Q1 2024 Earnings Release |
| 15/04/2024 13:05 | Q4 2023 Earnings Release |
| 04/04/2024 11:00 | Schizophrenia International Research Society Meeting - Poster No : T291 |
| 04/04/2024 09:25 | Schizophrenia International Research Society Meeting |
| 27/03/2024 23:00 | American Society for Clinical Pharmacology & Therapeutics Meeting |
| 19/03/2024 21:00 | Roth Conference |
| 18/03/2024 17:30 | UBS Virtual CNS Day |
| 26/02/2024 19:45 | BIO CEO & Investor Conference |
| 15/02/2024 17:00 | Investor Meeting - key Opinion Leader |
| 01/02/2024 17:30 | Lytham Partners Investor Select Conference - Fireside Chat |
| 17/01/2024 20:00 | Webull Live Virtual Healthcare Investment Conference |
| 14/12/2023 17:00 | Life Sciences Investor Forum |
| 06/12/2023 | Benchmark Company Discovery Conference |
| 14/11/2023 21:01 | Q3 2023 Earnings Release |
| 13/11/2023 19:00 | Annual General Meeting |
| 30/10/2023 12:30 | Phase 3 RECOVER Topline Results Conference Call |
| 12/09/2023 20:30 | H.C. Wainwright Global Investment Conference - Panel |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -2,43 -2,33 -4.54% | -10,1 -10,4 3.12% | -24,3 -21,0 -15.56% | -39,5 -38,6 -2.22% | -40,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,78 -2,80 -35.14% | -8,52 -9,15 6.97% | -24,3 -20,8 -16.96% | -39,2 -37,5 -4.64% | -39,6 |
|
Net income Million USD | Released Forecast Spread | -3,78 -2,80 -35.12% | -8,52 -9,16 6.98% | -24,3 -20,9 -16.41% | -39,3 -38,6 -1.75% | -39,6 |
|
EPS USD | Released Forecast Spread | -1,24 -0,17 -629.41% | -0,58 -0,63 8.42% | -1,25 -1,09 -14.94% | -1,65 -1,58 -4.21% | -1,11 |
| Announcement Date | 22/03/21 | 15/03/22 | 30/03/23 | 15/04/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -7,45 -4,49 -66.02% | -5,52 -6,64 16.85% | -3,56 -5,76 38.16% | -7,77 -4,50 -72.73% | -6,74 -7,35 8.4% | -12,1 -6,54 -84.51% | -10,7 -8,78 -22.01% | -9,99 -9,14 -9.33% | -7,92 -10,1 21.56% | -9,58 | -11,7 | -11,6 | -12,1 | -12,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,36 -4,49 -64.04% | -5,33 -6,64 19.65% | -3,51 -5,84 39.86% | -8,11 -4,33 -87.11% | -6,60 -7,30 9.63% | -12,4 -6,41 -94.1% | -10,5 -7,99 -31.09% | -9,73 -7,99 -21.71% | -7,43 -10,2 26.91% | -8,90 | -11,7 | -11,6 | -11,9 | -12,1 |
|
Net income Million USD | Released Forecast Spread | -7,37 -4,49 -64.09% | -5,34 -6,64 19.54% | -3,52 -5,84 39.83% | -8,12 -4,33 -87.3% | -6,60 -7,30 9.59% | -12,4 -6,41 -94.16% | -10,5 -8,00 -31.21% | -9,72 -8,00 -21.63% | -7,43 -10,2 26.83% | -8,90 | -11,7 | -11,6 | -11,9 | -12,1 |
|
EPS USD | Released Forecast Spread | -0,40 -0,25 -60% | -0,29 -0,35 17.14% | -0,18 -0,30 40% | -0,38 -0,22 -75.38% | -0,30 -0,31 1.64% | -0,55 -0,29 -89.66% | -0,44 -0,32 -36.65% | -0,35 -0,31 -12.9% | -0,25 -0,37 32.43% | -0,29 | -0,31 | -0,31 | -0,27 | -0,27 |
| Announcement Date | 16/05/22 | 15/08/22 | 14/11/22 | 30/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | 15/04/24 | 14/05/24 | - | - | - | - | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Reviva Pharmaceuticals Holdings, Inc.
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
